TLR4 and systemic sclerosis: Furthermore, fibronectin extra domain A (FnEDA), an endogenous TLR4 ligand, is elevated in the circulation and skin lesions of SSc patients and this FnEDA–TLR4 axis is implicated in cutaneous fibrosis [21].